Cue Biopharma Inc
(CUE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 187 | 151 | 68 | 26 | 1,000 |
| Gross Profit | 187 | 151 | 68 | 26 | 1,000 |
| Operating Expenses | 13,567 | 15,017 | 11,099 | 13,116 | 15,238 |
| Operating Income | -13,380 | -14,866 | -11,031 | -13,090 | -14,238 |
| Interest Expense | 370 | 358 | 124 | 206 | 25 |
| Other Income | 641 | 632 | 200 | 88 | 8 |
| Pre-tax Income | -13,109 | -14,592 | -10,955 | -13,208 | -14,255 |
| Net Income Continuous | -13,109 | -14,592 | -10,955 | -13,208 | -14,255 |
| Net Income | $-13,109 | $-14,592 | $-10,955 | $-13,208 | $-14,255 |
| EPS Basic Total Ops | -0.29 | -0.37 | -0.31 | -0.37 | -0.44 |
| EPS Basic Continuous Ops | -0.29 | -0.37 | -0.31 | -0.37 | -0.44 |
| EPS Diluted Total Ops | -0.29 | -0.37 | -0.31 | -0.37 | -0.44 |
| EPS Diluted Continuous Ops | -0.29 | -0.37 | -0.31 | -0.37 | -0.44 |
| EBITDA(a) | $-13,343 | $-14,873 | $-10,922 | $-12,866 | $-13,932 |